Abstract
Desmopressin nasal spray has been recognized in the literature as a successful treatment for nocturnal enuresis in patients on clozapine [1–5]. No serious adverse reactions have been previously reported in this population. This paper reports a case of severe hyponatraemia in a 47-year-old man with schizophrenia who was commenced on desmopressin nasal spray to treat clozapineinduced nocturnal enuresis. To our knowledge, this is the first such case report.
Original language | English |
---|---|
Pages (from-to) | 949-949 |
Number of pages | 1 |
Journal | Australian and New Zealand Journal of Psychiatry |
Volume | 39 |
Issue number | 10 |
DOIs | |
Publication status | Published - Oct 2005 |
Externally published | Yes |